{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T12:09:34Z","timestamp":1793880574054,"version":"4.7.0"},"reference-count":136,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","atherosclerosis-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Atherosclerosis"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.atherosclerosis.2017.12.027","type":"journal-article","created":{"date-parts":[[2017,12,25]],"date-time":"2017-12-25T15:05:58Z","timestamp":1514214358000},"page":"262-271","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":305,"special_numbering":"C","title":["The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation"],"prefix":"10.1016","volume":"269","author":[{"given":"Gonzalo J.","family":"Mart\u00ednez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S.","family":"Celermajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib1","first-page":"3","article-title":"Making a difference. The World Health Report 1999","volume":"25","year":"1999","journal-title":"Health Millions"},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.12.027_bib2","first-page":"939","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice","volume":"69","author":"Piepoli","year":"2016","journal-title":"Rev. Esp. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib3","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJMoa1002358","article-title":"A\u00a0prospective natural-history study of coronary atherosclerosis","volume":"364","author":"Stone","year":"2011","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2017.12.027_bib4","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1056\/NEJMoa0908628","article-title":"Platelet inhibition with cangrelor in patients undergoing PCI","volume":"361","author":"Harrington","year":"2009","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"22","key":"10.1016\/j.atherosclerosis.2017.12.027_bib5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/eurheartj\/ehv759","article-title":"Inflammatory cytokines in atherosclerosis: current therapeutic approaches","volume":"37","author":"Tousoulis","year":"2016","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.atherosclerosis.2015.04.783","article-title":"Novel anti-inflammatory therapies for the treatment of atherosclerosis","volume":"240","author":"Khan","year":"2015","journal-title":"Atherosclerosis"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.12.027_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1056\/NEJM197608122950707","article-title":"The pathogenesis of atherosclerosis (first of two parts)","volume":"295","author":"Ross","year":"1976","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib8","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1161\/01.RES.0000029784.15893.10","article-title":"Innate and adaptive immunity in the pathogenesis of atherosclerosis","volume":"91","author":"Hansson","year":"2002","journal-title":"Circ. Res."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.12.027_bib9","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/j.jacc.2009.09.009","article-title":"Leducq Transatlantic Network on A. Inflammation in atherosclerosis: from pathophysiology to practice","volume":"54","author":"Libby","year":"2009","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"17","key":"10.1016\/j.atherosclerosis.2017.12.027_bib10","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","article-title":"Monocytes in coronary artery disease and atherosclerosis: where are we now?","volume":"62","author":"Ghattas","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1172\/JCI29950","article-title":"Ly-6Chi monocytes dominate hypercholesterolemia-associated monocytosis and give rise to macrophages in atheromata","volume":"117","author":"Swirski","year":"2007","journal-title":"J.\u00a0Clin. Invest."},{"issue":"27","key":"10.1016\/j.atherosclerosis.2017.12.027_bib12","doi-asserted-by":"crossref","first-page":"10340","DOI":"10.1073\/pnas.0604260103","article-title":"Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of disease","volume":"103","author":"Swirski","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib13","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/ni.1836","article-title":"CD36 ligands promote sterile inflammation through assembly of a Toll-like receptor 4 and 6 heterodimer","volume":"11","author":"Stewart","year":"2010","journal-title":"Nat. Immunol."},{"issue":"7293","key":"10.1016\/j.atherosclerosis.2017.12.027_bib14","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/nature08938","article-title":"NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals","volume":"464","author":"Duewell","year":"2010","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.12.027_bib15","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/01.ATV.0000160340.72641.87","article-title":"Nuclear factor kappaB signaling in atherogenesis","volume":"25","author":"de Winther","year":"2005","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.tcm.2007.09.001","article-title":"Metalloproteinases and vulnerable atherosclerotic plaques","volume":"17","author":"Newby","year":"2007","journal-title":"Trends Cardiovasc. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib17","first-page":"1565","article-title":"Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques. Potential role of matrix-degrading metalloproteinases and implications for plaque rupture","volume":"92","author":"Shah","year":"1995","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib18","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1161\/CIRCRESAHA.111.257535","article-title":"Multiple roles for neutrophils in atherosclerosis","volume":"110","author":"Soehnlein","year":"2012","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2009.10.028","article-title":"Role of polymorphonuclear neutrophils in atherosclerosis: current state and future perspectives","volume":"210","author":"Baetta","year":"2010","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib20","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1161\/CIRCRESAHA.107.160697","article-title":"Protective role of CXC receptor 4\/CXC ligand 12 unveils the importance of neutrophils in atherosclerosis","volume":"102","author":"Zernecke","year":"2008","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/ATVBAHA.107.154807","article-title":"Accumulation of myeloperoxidase-positive neutrophils in atherosclerotic lesions in LDLR-\/- mice","volume":"28","author":"van Leeuwen","year":"2008","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib22","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.atherosclerosis.2008.04.009","article-title":"ApoE(-\/-)\/lysozyme M(EGFP\/EGFP) mice as a versatile model to study monocyte and neutrophil trafficking in atherosclerosis","volume":"202","author":"Rotzius","year":"2009","journal-title":"Atherosclerosis"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib23","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1160\/TH07-06-0387","article-title":"Subendothelial infiltration of neutrophil granulocytes and liberation of matrix-destabilizing enzymes in an experimental model of human neo-intima","volume":"99","author":"Dorweiler","year":"2008","journal-title":"Thromb. Haemostasis"},{"issue":"6\u20137","key":"10.1016\/j.atherosclerosis.2017.12.027_bib24","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.biocel.2008.01.004","article-title":"Human neutrophil elastase: mediator and therapeutic target in atherosclerosis","volume":"40","author":"Henriksen","year":"2008","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib25","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1189\/jlb.0203086","article-title":"Proteinase-3 directly activates MMP-2 and degrades gelatin and Matrigel; differential inhibition by (-)epigallocatechin-3-gallate","volume":"74","author":"Pezzato","year":"2003","journal-title":"J.\u00a0Leukoc. Biol."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.12.027_bib26","doi-asserted-by":"crossref","first-page":"4495","DOI":"10.1046\/j.1432-1327.2000.01498.x","article-title":"Immunohistochemical evidence for the myeloperoxidase\/H2O2\/halide system in human atherosclerotic lesions: colocalization of myeloperoxidase and hypochlorite-modified proteins","volume":"267","author":"Malle","year":"2000","journal-title":"Eur. J. Biochem.\/FEBS"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib27","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1172\/JCI8574","article-title":"Macrophage scavenger receptor CD36 is the major receptor for LDL modified by monocyte-generated reactive nitrogen species","volume":"105","author":"Podrez","year":"2000","journal-title":"J.\u00a0Clin. Invest."},{"issue":"44","key":"10.1016\/j.atherosclerosis.2017.12.027_bib28","doi-asserted-by":"crossref","first-page":"41279","DOI":"10.1074\/jbc.M106958200","article-title":"Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase","volume":"276","author":"Fu","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib29","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.atherosclerosis.2007.08.014","article-title":"Primed polymorphonuclear leukocytes constitute a possible link between inflammation and oxidative stress in hyperlipidemic patients","volume":"197","author":"Mazor","year":"2008","journal-title":"Atherosclerosis"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib30","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.ahj.2010.06.010","article-title":"Novel biomarkers in cardiovascular disease: update 2010","volume":"160","author":"Hochholzer","year":"2010","journal-title":"Am. Heart J."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.12.027_bib31","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1161\/CIRCRESAHA.116.304944","article-title":"Coronary neutrophil extracellular trap burden and deoxyribonuclease activity in ST-elevation acute coronary syndrome are predictors of ST-segment resolution and infarct size","volume":"116","author":"Mangold","year":"2015","journal-title":"Circ. Res."},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib32","first-page":"220","article-title":"Neutrophil biology: an update","volume":"14","author":"Kobayashi","year":"2015","journal-title":"EXCLI J."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib33","doi-asserted-by":"crossref","DOI":"10.1042\/BSR20160430","article-title":"Neutrophil-derived microparticles are released into the coronary circulation following percutaneous coronary intervention in acute coronary syndrome patients","volume":"37","author":"Martinez","year":"2017","journal-title":"Biosci. Rep."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.12.027_bib34","doi-asserted-by":"crossref","first-page":"2894","DOI":"10.1161\/01.CIR.0000042674.89762.20","article-title":"Neutrophil infiltration of culprit lesions in acute coronary syndromes","volume":"106","author":"Naruko","year":"2002","journal-title":"Circulation"},{"issue":"1 Pt 1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib35","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0002-8703(96)90384-1","article-title":"Band neutrophil count and the presence and severity of coronary atherosclerosis","volume":"132","author":"Kawaguchi","year":"1996","journal-title":"Am. Heart J."},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib36","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.immunol.021908.132715","article-title":"The inflammasomes: guardians of the body","volume":"27","author":"Martinon","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.12.027_bib37","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1182\/blood.V95.10.3223","article-title":"The gene for familial Mediterranean fever, MEFV, is expressed in early leukocyte development and is regulated in response to inflammatory mediators","volume":"95","author":"Centola","year":"2000","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1038\/nri2725","article-title":"NLRP3 inflammasome activation: the convergence of multiple signalling pathways on ROS production?","volume":"10","author":"Tschopp","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.12.027_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tcb.2009.06.002","article-title":"Molecular mechanisms involved in inflammasome activation","volume":"19","author":"Bryant","year":"2009","journal-title":"Trends Cell Biol."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.12.027_bib40","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1002\/art.22938","article-title":"The role of interleukin-1 and the inflammasome in gout: implications for therapy","volume":"56","author":"Pope","year":"2007","journal-title":"Arthritis Rheum."},{"issue":"45","key":"10.1016\/j.atherosclerosis.2017.12.027_bib41","doi-asserted-by":"crossref","first-page":"41985","DOI":"10.1074\/jbc.M107419200","article-title":"Physiological concentrations of K+ inhibit cytochrome c-dependent formation of the apoptosome","volume":"276","author":"Cain","year":"2001","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5876","key":"10.1016\/j.atherosclerosis.2017.12.027_bib42","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1126\/science.1156995","article-title":"Innate immune activation through Nalp3 inflammasome sensing of asbestos and silica","volume":"320","author":"Dostert","year":"2008","journal-title":"Science"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib43","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1038\/ni.1631","article-title":"Silica crystals and aluminum salts activate the NALP3 inflammasome through phagosomal destabilization","volume":"9","author":"Hornung","year":"2008","journal-title":"Nat. Immunol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib44","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ni.1831","article-title":"Thioredoxin-interacting protein links oxidative stress to inflammasome activation","volume":"11","author":"Zhou","year":"2010","journal-title":"Nat. Immunol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.12.027_bib45","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1172\/JCI40599","article-title":"Inflammasomes: too big to miss","volume":"119","author":"Stutz","year":"2009","journal-title":"J.\u00a0Clin. Invest."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib46","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1038\/ni.2231","article-title":"Sensing and reacting to microbes through the inflammasomes","volume":"13","author":"Franchi","year":"2012","journal-title":"Nat. Immunol."},{"issue":"24","key":"10.1016\/j.atherosclerosis.2017.12.027_bib47","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1161\/CIRCULATIONAHA.107.746453","article-title":"Critical role of bone marrow apoptosis-associated speck-like protein, an inflammasome adaptor molecule, in neointimal formation after vascular injury in mice","volume":"117","author":"Yajima","year":"2008","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.12.027_bib48","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0011765","article-title":"Cholesterol crystals activate the NLRP3 inflammasome in human macrophages: a novel link between cholesterol metabolism and inflammation","volume":"5","author":"Rajamaki","year":"2010","journal-title":"PLoS One"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.12.027_bib49","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1042\/CS20160090","article-title":"Colchicine therapy in acute coronary syndrome patients acts on caspase-1 to suppress NLRP3 inflammasome monocyte activation","volume":"130","author":"Robertson","year":"2016","journal-title":"Clin. Sci."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.12.027_bib50","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1194\/jlr.M018077","article-title":"Identification of cholesterol crystals in plaques of atherosclerotic mice using hyperspectral CARS imaging","volume":"52","author":"Lim","year":"2011","journal-title":"J.\u00a0Lipid Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.12.027_bib51","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MCA.0000000000000255","article-title":"NLRP3 inflammasome in peripheral blood monocytes of acute coronary syndrome patients and its relationship with statins","volume":"26","author":"Altaf","year":"2015","journal-title":"Coron. Artery Dis."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib52","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib53","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1182\/blood-2008-02-139634","article-title":"Neutrophil secretion products pave the way for inflammatory monocytes","volume":"112","author":"Soehnlein","year":"2008","journal-title":"Blood"},{"issue":"6245","key":"10.1016\/j.atherosclerosis.2017.12.027_bib54","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1126\/science.aaa8064","article-title":"Inflammation. Neutrophil extracellular traps license macrophages for cytokine production in atherosclerosis","volume":"349","author":"Warnatsch","year":"2015","journal-title":"Science"},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.12.027_bib55","doi-asserted-by":"crossref","first-page":"3720","DOI":"10.1182\/blood-2010-07-273417","article-title":"interleukin-1 in the pathogenesis and treatment of inflammatory diseases","volume":"117","author":"Dinarello","year":"2011","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.atherosclerosis.2017.12.027_bib56","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1038\/ni1110-973","article-title":"IL-1 family nomenclature","volume":"11","author":"Dinarello","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib57","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1146\/annurev.immunol.021908.132612","article-title":"Immunological and inflammatory functions of the interleukin-1 family","volume":"27","author":"Dinarello","year":"2009","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib58","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1084\/jem.20071868","article-title":"IL-33 reduces the development of atherosclerosis","volume":"205","author":"Miller","year":"2008","journal-title":"J.\u00a0Exp. Med."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib59","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.immuni.2013.11.010","article-title":"The interleukin-1 family: back to the future","volume":"39","author":"Garlanda","year":"2013","journal-title":"Immunity"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib60","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/nri2691","article-title":"The IL-1 family: regulators of immunity","volume":"10","author":"Sims","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib61","doi-asserted-by":"crossref","first-page":"4987","DOI":"10.4049\/jimmunol.172.8.4987","article-title":"A\u00a0novel P2X7 receptor activator, the human cathelicidin-derived peptide LL37, induces IL-1 beta processing and release","volume":"172","author":"Elssner","year":"2004","journal-title":"J.\u00a0Immunol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.12.027_bib62","doi-asserted-by":"crossref","first-page":"13757","DOI":"10.1074\/jbc.270.23.13757","article-title":"Molecular cloning and characterization of a second subunit of the interleukin 1 receptor complex","volume":"270","author":"Greenfeder","year":"1995","journal-title":"J.\u00a0Biol. Chem."},{"issue":"5120","key":"10.1016\/j.atherosclerosis.2017.12.027_bib63","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1126\/science.8332913","article-title":"interleukin-1 type II receptor: a decoy target for IL-1 that is regulated by IL-4","volume":"261","author":"Colotta","year":"1993","journal-title":"Science"},{"issue":"1\u20132","key":"10.1016\/j.atherosclerosis.2017.12.027_bib64","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0041-1345(98)02109-5","article-title":"interleukin-1 beta induces endothelin-1 gene by multiple mechanisms","volume":"31","author":"Herman","year":"1999","journal-title":"Transplant. Proc."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib65","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/0021-9150(94)05503-B","article-title":"interleukin-1 beta induces expression of adhesion molecules in human vascular smooth muscle cells and enhances adhesion of leukocytes to smooth muscle cells","volume":"115","author":"Wang","year":"1995","journal-title":"Atherosclerosis"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib66","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1038\/nri3024","article-title":"Neutrophils in the activation and regulation of innate and adaptive immunity","volume":"11","author":"Mantovani","year":"2011","journal-title":"Nat. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib67","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.ijcard.2008.04.059","article-title":"Macrophage roles following myocardial infarction","volume":"130","author":"Lambert","year":"2008","journal-title":"Int. J. Cardiol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib68","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1152\/physrev.00024.2005","article-title":"Cytokines in atherosclerosis: pathogenic and regulatory pathways","volume":"86","author":"Tedgui","year":"2006","journal-title":"Physiol. Rev."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib69","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.ATV.0000064374.15232.C3","article-title":"Lack of interleukin-1beta decreases the severity of atherosclerosis in ApoE-deficient mice","volume":"23","author":"Kirii","year":"2003","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.12.027_bib70","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1161\/01.CIR.0000142085.39015.31","article-title":"interleukin-1 receptor signaling mediates atherosclerosis associated with bacterial exposure and\/or a high-fat diet in a murine apolipoprotein E heterozygote model: pharmacotherapeutic implications","volume":"110","author":"Chi","year":"2004","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib71","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/01.ATV.16.8.1000","article-title":"interleukin-1 beta in coronary arteries of patients with ischemic heart disease","volume":"16","author":"Galea","year":"1996","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib72","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.ijcard.2014.07.151","article-title":"A\u00a0safe and easy technique to sample the coronary sinus\u2013facilitating a closer look at cardiac disease","volume":"176","author":"Martinez","year":"2014","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib73","article-title":"Colchicine acutely suppresses local cardiac production of inflammatory cytokines in patients with an acute coronary syndrome","volume":"4","author":"Martinez","year":"2015","journal-title":"J.\u00a0Am. Heart Assoc."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib74","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/FJC.0b013e3181c87e53","article-title":"interleukin-1 trap attenuates cardiac remodeling after experimental acute myocardial infarction in mice","volume":"55","author":"Van Tassell","year":"2010","journal-title":"J.\u00a0Cardiovasc. Pharmacol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib75","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2353\/ajpath.2008.070974","article-title":"interleukin-1 receptor type I signaling critically regulates infarct healing and cardiac remodeling","volume":"173","author":"Bujak","year":"2008","journal-title":"Am. J. Pathol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib76","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1056\/NEJMoa1701719","article-title":"Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease","volume":"377","author":"Jaiswal","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"6327","key":"10.1016\/j.atherosclerosis.2017.12.027_bib77","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1126\/science.aag1381","article-title":"Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice","volume":"355","author":"Fuster","year":"2017","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib78","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.smim.2013.10.005","article-title":"Interleukin-1alpha","volume":"25","author":"Rider","year":"2013","journal-title":"Semin. Immunol."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.12.027_bib79","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.4049\/jimmunol.1102048","article-title":"IL-1alpha and IL-1beta recruit different myeloid cells and promote different stages of sterile inflammation","volume":"187","author":"Rider","year":"2011","journal-title":"J.\u00a0Immunol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib80","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.4049\/jimmunol.0901080","article-title":"Cutting edge: necrosis activates the NLRP3 inflammasome","volume":"183","author":"Li","year":"2009","journal-title":"J.\u00a0Immunol."},{"issue":"5297","key":"10.1016\/j.atherosclerosis.2017.12.027_bib81","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.275.5297.206","article-title":"Activation of interferon-gamma inducing factor mediated by interleukin-1beta converting enzyme","volume":"275","author":"Gu","year":"1997","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib82","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.immuni.2009.05.005","article-title":"Inflammasome-mediated disease animal models reveal roles for innate but not adaptive immunity","volume":"30","author":"Brydges","year":"2009","journal-title":"Immunity"},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib83","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3389\/fimmu.2013.00289","article-title":"interleukin-18 and IL-18 binding protein","volume":"4","author":"Dinarello","year":"2013","journal-title":"Front. Immunol."},{"issue":"14","key":"10.1016\/j.atherosclerosis.2017.12.027_bib84","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1161\/hc3901.096721","article-title":"Expression of interleukin-18 in human atherosclerotic plaques and relation to plaque instability","volume":"104","author":"Mallat","year":"2001","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib85","doi-asserted-by":"crossref","first-page":"E34","DOI":"10.1161\/hh0202.105292","article-title":"interleukin-18 enhances atherosclerosis in apolipoprotein E(-\/-) mice through release of interferon-gamma","volume":"90","author":"Whitman","year":"2002","journal-title":"Circ. Res."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib86","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0008-6363(03)00343-2","article-title":"Reduced atherosclerosis in interleukin-18 deficient apolipoprotein E-knockout mice","volume":"59","author":"Elhage","year":"2003","journal-title":"Cardiovasc. Res."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.12.027_bib87","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.1073\/pnas.041611398","article-title":"Inhibition of caspase 1 reduces human myocardial ischemic dysfunction via inhibition of IL-18 and IL-1beta","volume":"98","author":"Pomerantz","year":"2001","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"9","key":"10.1016\/j.atherosclerosis.2017.12.027_bib88","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/ATVBAHA.107.149484","article-title":"interleukin-18, the metabolic syndrome, and subclinical atherosclerosis: results from the Dallas Heart Study","volume":"27","author":"Zirlik","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib89","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2011.03.015","article-title":"Interleukin 18 and coronary heart disease: prospective study and systematic review","volume":"217","author":"Jefferis","year":"2011","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib90","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1161\/01.CIR.0000020546.30940.92","article-title":"interleukin-18 is a strong predictor of cardiovascular death in sTable\u00a0and unsTable\u00a0angina","volume":"106","author":"Blankenberg","year":"2002","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.12.027_bib91","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1161\/CIRCULATIONAHA.104.519702","article-title":"Genetic analysis of the interleukin-18 system highlights the role of the interleukin-18 gene in cardiovascular disease","volume":"112","author":"Tiret","year":"2005","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib92","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1161\/01.RES.0000232324.87983.4b","article-title":"Haplotypes of the caspase-1 gene, plasma caspase-1 levels, and cardiovascular risk","volume":"99","author":"Blankenberg","year":"2006","journal-title":"Circ. Res."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.12.027_bib93","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N.\u00a0Engl. J. Med."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib94","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/nm.3806","article-title":"A\u00a0small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases","volume":"21","author":"Coll","year":"2015","journal-title":"Nat. Med."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib95","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1161\/ATVBAHA.117.309575","article-title":"NLRP3 inflammasome inhibition by MCC950 reduces atherosclerotic lesion development in apolipoprotein e-deficient mice-brief report","volume":"37","author":"van der Heijden","year":"2017","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.12.027_bib96","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1002\/jcp.24903","article-title":"Resveratrol inhibits NLRP3 inflammasome activation by preserving mitochondrial integrity and augmenting autophagy","volume":"230","author":"Chang","year":"2015","journal-title":"J.\u00a0Cell. Physiol."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.12.027_bib97","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1111\/cns.12349","article-title":"Activating cannabinoid receptor 2 alleviates pathogenesis of experimental autoimmune encephalomyelitis via activation of autophagy and inhibiting NLRP3 inflammasome","volume":"20","author":"Shao","year":"2014","journal-title":"CNS Neurosci. Ther."},{"issue":"12","key":"10.1016\/j.atherosclerosis.2017.12.027_bib98","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1161\/CIRCULATIONAHA.114.013730","article-title":"Anti-inflammatory and antiatherogenic effects of the NLRP3 inflammasome inhibitor arglabin in ApoE2.Ki mice fed a high-fat diet","volume":"131","author":"Abderrazak","year":"2015","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib99","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.immuni.2011.02.006","article-title":"Type I interferon inhibits interleukin-1 production and inflammasome activation","volume":"34","author":"Guarda","year":"2011","journal-title":"Immunity"},{"issue":"Pt 3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib100","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1093\/brain\/awu388","article-title":"NLRP3 inflammasome is associated with the response to IFN-beta in patients with multiple sclerosis","volume":"138","author":"Malhotra","year":"2015","journal-title":"Brain J. Neurol."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib101","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1093\/eurheartj\/ehu272","article-title":"The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study","volume":"36","author":"Morton","year":"2015","journal-title":"Eur. Heart J."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.12.027_bib102","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjcard.2009.12.059","article-title":"interleukin-1 blockade with anakinra to prevent adverse cardiac remodeling after acute myocardial infarction (Virginia Commonwealth University Anakinra Remodeling Trial [VCU-ART] Pilot study)","volume":"105","author":"Abbate","year":"2010","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib103","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.amjcard.2014.11.003","article-title":"Comparative safety of interleukin-1 blockade with anakinra in patients with ST-segment elevation acute myocardial infarction (from the VCU-ART and VCU-ART2 pilot studies)","volume":"115","author":"Abbate","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib104","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S2213-8587(15)00034-0","article-title":"Cardiometabolic effects of genetic upregulation of the interleukin 1 receptor antagonist: a Mendelian randomisation analysis","volume":"3","author":"interleukin 1 Genetics","year":"2015","journal-title":"Lancet Diabetes Endocrinol."},{"issue":"23","key":"10.1016\/j.atherosclerosis.2017.12.027_bib105","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1161\/CIRCULATIONAHA.112.122556","article-title":"Effects of interleukin-1beta inhibition with canakinumab on hemoglobin A1c, lipids, C-reactive protein, interleukin-6, and fibrinogen: a phase IIb randomized, placebo-controlled trial","volume":"126","author":"Ridker","year":"2012","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s11926-002-0073-2","article-title":"Update on colchicine and its mechanism of action","volume":"4","author":"Molad","year":"2002","journal-title":"Curr. Rheumatol. Rep."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib107","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.jbspin.2006.03.006","article-title":"Colchicine today","volume":"73","author":"Niel","year":"2006","journal-title":"Joint Bone Spine Rev. Rhum."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib108","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/med.20097","article-title":"Anti-mitotic activity of colchicine and the structural basis for its interaction with tubulin","volume":"28","author":"Bhattacharyya","year":"2008","journal-title":"Med. Res. Rev."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib109","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1172\/JCI118147","article-title":"Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils","volume":"96","author":"Cronstein","year":"1995","journal-title":"J.\u00a0Clin. Invest."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib110","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.semarthrit.2015.06.013","article-title":"Colchicine\u2013Update on mechanisms of action and therapeutic uses","volume":"45","author":"Leung","year":"2015","journal-title":"Semin. Arthritis Rheum."},{"issue":"7081","key":"10.1016\/j.atherosclerosis.2017.12.027_bib111","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature04516","article-title":"Gout-associated uric acid crystals activate the NALP3 inflammasome","volume":"440","author":"Martinon","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.12.027_bib112","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1038\/ni.2550","article-title":"Microtubule-driven spatial arrangement of mitochondria promotes activation of the NLRP3 inflammasome","volume":"14","author":"Misawa","year":"2013","journal-title":"Nat. Immunol."},{"issue":"50","key":"10.1016\/j.atherosclerosis.2017.12.027_bib113","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1073\/pnas.1613156113","article-title":"Familial Mediterranean fever mutations lift the obligatory requirement for microtubules in Pyrin inflammasome activation","volume":"113","author":"Van Gorp","year":"2016","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib114","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/ni.3457","article-title":"Pyrin inflammasome activation and RhoA signaling in the autoinflammatory diseases FMF and HIDS","volume":"17","author":"Park","year":"2016","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib115","doi-asserted-by":"crossref","first-page":"32587","DOI":"10.1038\/srep32587","article-title":"Colchicine prevents NSAID-induced small intestinal injury by inhibiting activation of the NLRP3 inflammasome","volume":"6","author":"Otani","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib116","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/j.hlc.2017.06.060","article-title":"Anti-inflammatory effects of colchicine on oxidised low-density lipoproteins and cholesterol crystal-induced macrophage activation in\u00a0vitro","volume":"26","author":"Fernando","year":"2016","journal-title":"Heart Lung Circ."},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib117","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1136\/annrheumdis-2015-208690","article-title":"EULAR recommendations for the management of familial Mediterranean fever","volume":"75","author":"Ozen","year":"2016","journal-title":"Ann. Rheum. Dis."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib118","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1177\/1074248413499972","article-title":"Targeting cholesterol crystal-induced inflammation for the secondary prevention of cardiovascular disease","volume":"19","author":"Nidorf","year":"2014","journal-title":"J.\u00a0Cardiovasc. Pharmacol. Therapeut."},{"issue":"5","key":"10.1016\/j.atherosclerosis.2017.12.027_bib119","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1111\/j.1476-5381.2011.01254.x","article-title":"Colchicine inhibits cationic dye uptake induced by ATP in P2X2 and P2X7 receptor-expressing cells: implications for its therapeutic action","volume":"163","author":"Marques-da-Silva","year":"2011","journal-title":"Br. J. Pharmacol."},{"issue":"2","key":"10.1016\/j.atherosclerosis.2017.12.027_bib120","first-page":"92","article-title":"Growth-inhibiting effect of colchicine on cultured vascular wall myocytes from arteriosclerotic lesions","volume":"81","author":"Bauriedel","year":"1992","journal-title":"Zeitschrift fur Kardiologie"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib121","first-page":"343","article-title":"The effect of colchicine on the development of experimental atherosclerosis in rabbits","volume":"38","author":"Wojcicki","year":"1986","journal-title":"Pol. J. Pharmacol. Pharm."},{"issue":"2\u20133","key":"10.1016\/j.atherosclerosis.2017.12.027_bib122","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/0021-9150(76)90028-9","article-title":"Effects of methyl prednisolone and colchicine on the development of aortic atherosclerosis in swine","volume":"25","author":"Lee","year":"1976","journal-title":"Atherosclerosis"},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib123","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-511X-13-67","article-title":"Synergistic effects of colchicine combined with atorvastatin in rats with hyperlipidemia","volume":"13","author":"Huang","year":"2014","journal-title":"Lipids Health Dis."},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib124","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.ijcard.2017.03.126","article-title":"Interest of colchicine in the treatment of acute myocardial infarct responsible for heart failure in a mouse model","volume":"240","author":"Akodad","year":"2017","journal-title":"Int. J. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib125","first-page":"1174","article-title":"Colchicine improves survival, left ventricular remodeling, and chronic cardiac function after acute myocardial infarction","volume":"81","author":"Fujisue","year":"2017","journal-title":"Circ. J. Offic. J. Jpn. Circ. Soc."},{"issue":"6","key":"10.1016\/j.atherosclerosis.2017.12.027_bib126","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.amjcard.2006.10.039","article-title":"Effect of colchicine (0.5 mg twice daily) on high-sensitivity C-reactive protein independent of aspirin and atorvastatin in patients with sTable\u00a0coronary artery disease","volume":"99","author":"Nidorf","year":"2007","journal-title":"Am. J. Cardiol."},{"issue":"1","key":"10.1016\/j.atherosclerosis.2017.12.027_bib127","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s11239-011-0637-y","article-title":"Effect of colchicine compared with placebo on high sensitivity C-reactive protein in patients with acute coronary syndrome or acute stroke: a pilot randomized controlled trial","volume":"33","author":"Raju","year":"2012","journal-title":"J.\u00a0Thromb. Thrombolysis"},{"key":"10.1016\/j.atherosclerosis.2017.12.027_bib128","article-title":"Colchicine therapy and plaque stabilization in patients with acute coronary syndrome: a CT coronary angiography study","author":"Vaidya","year":"2017","journal-title":"JACC Cardiovasc. Imag."},{"issue":"10","key":"10.1016\/j.atherosclerosis.2017.12.027_bib129","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.amjcard.2015.02.036","article-title":"Usefulness of colchicine to reduce perioperative myocardial damage in patients who underwent on-pump coronary artery bypass grafting","volume":"115","author":"Giannopoulos","year":"2015","journal-title":"Am. J. Cardiol."},{"issue":"15","key":"10.1016\/j.atherosclerosis.2017.12.027_bib130","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1161\/CIRCULATIONAHA.115.017611","article-title":"Anti-inflammatory treatment with colchicine in acute myocardial infarction: a pilot study","volume":"132","author":"Deftereos","year":"2015","journal-title":"Circulation"},{"issue":"6\u2013","key":"10.1016\/j.atherosclerosis.2017.12.027_bib131","first-page":"396","article-title":"COLIN trial: value of colchicine in the treatment of patients with acute myocardial infarction and inflammatory response","volume":"110","author":"Akodad","year":"2017","journal-title":"Arch. cardiovasc. Dis."},{"issue":"7","key":"10.1016\/j.atherosclerosis.2017.12.027_bib132","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.3899\/jrheum.111533","article-title":"Colchicine use is associated with decreased prevalence of myocardial infarction in patients with gout","volume":"39","author":"Crittenden","year":"2012","journal-title":"J.\u00a0Rheumatol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib133","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1136\/heartjnl-2015-308542","article-title":"Cardiovascular effects and safety of long-term colchicine treatment: Cochrane review and meta-analysis","volume":"102","author":"Hemkens","year":"2016","journal-title":"Heart"},{"issue":"4","key":"10.1016\/j.atherosclerosis.2017.12.027_bib134","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jacc.2012.10.027","article-title":"Low-dose colchicine for secondary prevention of cardiovascular disease","volume":"61","author":"Nidorf","year":"2013","journal-title":"J.\u00a0Am. Coll. Cardiol."},{"issue":"8","key":"10.1016\/j.atherosclerosis.2017.12.027_bib135","first-page":"429","article-title":"Binding of colchicine and thiocolchicoside to human serum proteins and blood cells","volume":"32","author":"Sabouraud","year":"1994","journal-title":"Int. J. Clin. Pharmacol. Therapeut."},{"issue":"3","key":"10.1016\/j.atherosclerosis.2017.12.027_bib136","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0049-0172(91)90003-I","article-title":"Colchicine intoxication: clinical pharmacology, risk factors, features, and management","volume":"21","author":"Putterman","year":"1991","journal-title":"Semin. Arthritis Rheum."}],"updated-by":[{"DOI":"10.1016\/j.atherosclerosis.2018.03.043","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000}}],"container-title":["Atherosclerosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314569?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021915017314569?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,10,24]],"date-time":"2020-10-24T22:09:39Z","timestamp":1603577379000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021915017314569"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":136,"alternative-id":["S0021915017314569"],"URL":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.12.027","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/j.atherosclerosis.2018.03.043","asserted-by":"object"}]},"ISSN":["0021-9150"],"issn-type":[{"value":"0021-9150","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The NLRP3 inflammasome and the emerging role of colchicine to inhibit atherosclerosis-associated inflammation","name":"articletitle","label":"Article Title"},{"value":"Atherosclerosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.atherosclerosis.2017.12.027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}